Olli Kärkkäinen
banner
ollikarkkainen.bsky.social
Olli Kärkkäinen
@ollikarkkainen.bsky.social
790 followers 760 following 59 posts
Senior researcher in drug toxicology at University of Eastern Finland and co-founder and CEO of Afekta Technologies Ltd. Metabolomics, biomarkers, alcohol, drugs, nutrition, disease progression, treatment responses. https://orcid.org/0000-0003-0825-4956
Posts Media Videos Starter Packs
Interesting new paper on using multi-omics data-analysis methods in integrative holo-omics data-analysis. We were happy to contribute to the metabolomics part.

Congrats @jennymerkesvik.bsky.social‬ for the excellent work!
Check out this preprint of the first article for my PhD thesis!
www.biorxiv.org/content/10.1...

We've leveraged methods developed for multi-omics to investigate a holo-omic system (🐷🦠), and predicted host-microbiome interactions between important features for observed cross-omic data patterns 🔍📊
Reposted by Olli Kärkkäinen
Interesting new analysis of ADHD meds in schizophrenia-spectrum disorders: reduced risk of psychosis with atomoxetine and reduced risk for somatic hospitalizations with lisdexamphetamine.

Higher somatic hospitalization with polytherapy, no other negative safety signals. #psychiatry #medsky
We were able to get good metabolite profiles from microscopically small chicken gut samples. And show metabolite profile effects of Salmonella infection in different parts of the gut (central lumen, mucosal lumen or host tissue) and that synbiotic treatment can alleviate some of these changes.
Today in the #MetSoc2025 conference, I was presenting a poster about the microsample global metabolomics method development we have been doing in the 3D'omics project at Afekta Technologies !
Reposted by Olli Kärkkäinen
Heading to #Metabolomics2025? Here are some quick tips:
✅ Prague Congress Centre is easy to reach by public transport
✅ It can get warm – pack a water bottle
✅ Conference essentials: poster, laptop, and charger
✅ Check out the full agenda here: tinyurl.com/4vudznw8
#Prague2025 #EMN #ConferenceTips
Agenda - Metabolomics 2025
www.metabolomics2025.org
Reposted by Olli Kärkkäinen
Reposted by Olli Kärkkäinen
Thank you!

For the human post-mortem study, unfortunately the ethical approval does not allow for public sharing of the data.

For the pig heart study, there is a plan for public release of the metabolomics data of also other analysed organs in the near future.
And of course we also celebrated the Midsummer!
... And a first first author paper for talented doctoral researcher Reta Haikonen: Blueprint of the distinct metabolite profiles of healthy pig heart chambers:
doi.org/10.1016/j.jm...
Redirecting
doi.org
This is the first first author manuscript for the excellent doctoral researcher Dennisse Avella! This study was part of the @human-dn.bsky.social with great co-authors: Soile Turunen, Glykeria Avgerinou, Anatoli Petridou, Vassilis Mougios, Iman Zarei, Seppo Auriola and Kati Hanhineva
Reposted by Olli Kärkkäinen
HS:n eilisessä velka-artikkelissa sivuutettiin lähes kokonaan valtionvelan hoitokustanukset ja inflaatio. Vaikka valtionvelan määrä on kasvanut, se kuormittaa julkista taloutta 2000-luvun alkua vähemmän, koska Suomi saa lainaa paljon aiempaa halvemmalla ja inflaatio pienentää lainapääoman arvoa. 1/
Reposted by Olli Kärkkäinen
METABOLOMIC INSIGHTS: LC-MS PROFILING OF HUMAN PLACENTAL TISSUE FROM SSRI-TREATED PREGNANCIES https://www.medrxiv.org/content/10.1101/2025.05.12.25327429v1
Reposted by Olli Kärkkäinen
🚨 📢 I’m #hiring!!! I am looking for an experienced #metabolomics scientist with a particular focus on LC-MS. Please follow the link below for more details and how to apply! 📢 🚨
Applications close at 23:59 on May 23rd!!!

www.crick.ac.uk/careers-stud...
Senior/Principal Laboratory Research Scientist: Metabolomics & Lipidomics Specialist
www.crick.ac.uk
Reposted by Olli Kärkkäinen
Important update! Thinking of submitting a poster abstract? Do not delay. Due to the high (and exciting!) volume of abstracts we will likely close abstract submission BEFORE May 15. Submit your abstract ASAP!